Search
forResearch 10 of 96
- Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss
- Pilot study: genetic distribution of AR, FGF5, SULT1A1 and CYP3A5 polymorphisms in male Mexican population with androgenetic alopecia.
- Investigations of 13 Genes in Non-Cicatricial Alopecia
- Epidemiologic Study of Gene Distribution in Romanian and Brazilian Patients with Non-Cicatricial Alopecia
- 26-SNP Panel Aids Guiding Androgenetic Alopecia Therapy and Provides Insight into Mechanisms of Action
- Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen
- Application of big data analytics in minoxidil drug development: a data-driven model for predicting efficacy and side effect risks
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Precision-Based Management of Chronic Hair Fall: A Genomic-Guided Trichology Approach - A Case Analysis from Qatar
- SULT1A1 enzyme booster to amplify topical minoxidil response in androgenic alopecia: a single-center prospective study
Community 8 of 17
- Physio-metabolic method (antiandrogen, minoxidil, leg training and cold)
- Will oral minoxidil work if you're missing the SULT1A1 enzyme?
- Oral Minoxidil - The Hyper-Responder Concept
- How is it possible for someone to be a non responder to ORAL minoxidil?
- Oral Minoxidil appears to work substantially better in patients with low SULT1A1 enzyme activity
- This true? Sult1a1 enzyme booster 2025
- Increasing activity of the sult1a1 enzyme via alkalizing agent and tretinoin for better response to topical minoxidil
- MinoxiBoost - SULT1A1 Enzyme booster journey
Learn
— no results
Try a deeper search in learn →